Back to Services

 



 

Site Assessment Services

Investigator site acceptance and use of EDC is instrumental in the success of accelerating clinical trials data collection and FDA acceptance of drug application submissions. Many investigator sites are not part of a biopharma’s decision-making process to use EDC and are often resistant to the technology. Furthermore, many investigators are not prepared to implement EDC from a computer hardware and Internet-access viewpoint. In turn, investigator sites may cause trial delays since extra time is needed to configure the site for efficient EDC operations. EDC Management can facilitate investigator site communications and assessments to insure an effective EDC deployment, either for an initial company-wide roll-out, or for a single clinical trial protocol.

Site Assessment Offerings:
EDC Pre-Adoption Assessment
Assessment of clinical trials, number of sites and location of sites
EDC survey of investigator sites, including technology
Summary site report on hardware, Internet and computer expertise
Conclusive assessment to support an EDC decision

Deployment and Technology Assessment
Survey and analysis of investigator’s hardware and Internet capabilities
Site visits for issue resolution
Summary site report on hardware, Internet and computer expertise
Planning and execution of site upgrades

Ongoing EDC Site Training and Support
Survey of prepared investigator sites
Comprehensive site training
Help desk support

Back To Top


Home | About Us | Services
Subscribers Only | Contact Us

EDC Management
P.O. Box 23 Conshohocken, PA 19428
484-530-0300 Fax: 610-567-0357
Email: info@edcmanagement.com

©2002-2005 EDC Technologies LLC. All rights reserved. “EDC Technologies” is a service mark of EDC Technologies LLC. “EDC Today” is registered in the U.S. Patent and Trademark Office. All other marks and trade names are the property of the respective companies..